{
  "paper_metadata": {
    "pmid": "36471404",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 13,
        "demographics": "Median age at diagnosis was 42 years (30\u201375); all were affected individuals.",
        "phenotype": "All had sensorimotor polyneuropathy, with some having additional symptoms."
      },
      "penetrance_data": {
        "total_carriers_observed": 13,
        "affected_count": 13,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 42,
          "age_at_onset": null,
          "age_at_diagnosis": 42,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "sensorimotor polyneuropathy",
          "evidence_sentence": "Among patients with p.Val50Met mutation, the median age at diagnosis was 42 years (30\u201375)."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 67,
          "age_at_onset": null,
          "age_at_diagnosis": 67,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "ATTR-CM, 20% had ATTR-PN, and 40% carpal tunnel syndrome.",
          "evidence_sentence": "Patients carrying p.Val142Ile mutation had a median age of 67 years (54\u201369) at diagnosis."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 45,
          "age_at_onset": null,
          "age_at_diagnosis": 45,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "mixed phenotype of ATTR-CM and ATTR-PN.",
          "evidence_sentence": "The patient with p.Glu109Lys mutation was diagnosed by the age of 45 years and had a mixed phenotype of ATTR-CM and ATTR-PN."
        }
      ],
      "functional_data": {
        "summary": "The mutations identified in TTR were associated with clinical manifestations of amyloidosis.",
        "assays": []
      },
      "segregation_data": "The variants segregate with disease in families as they are associated with clinical symptoms.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "All identified mutations were linked to clinical presentations of amyloidosis.",
      "key_quotes": [
        "Thirteen patients had ATTRv, with the following mutations identified: p.Val50Met (54%; n\u2009=\u20097), p.Val142Ile (38%; n\u2009=\u20095), and p.Glu109Lys (8%; n\u2009=\u20091)."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Data was extracted thoroughly from the main text."
  }
}